Ancora Heart announced that it entered into a strategic partnership with Egnite to accelerate clinical trial enrollment. The partnership centers around the Ancora Heart CORCINCH-HF pivotal clinical trial. It evaluates the safety and efficacy of the AccuCinch ventricular restoration system. Together, the companies aim to combine cutting-edge technology and expertise to deliver therapies to patients […]
Ancora Heart
AccuCinch ventricular restoration system from Ancora Heart improves heart failure outcomes
Ancora Heart announced today that its AccuCinch system demonstrated improvement in heart failure patient outcomes in an analysis. Patients treated with the investigational device also saw beneficial changes in the structure of the heart. Twelve-month data were presented at the Technology and Heart Failure Therapeutics conference (THT 2023) and simultaneously published in the Journal of Cardiac […]
Ancora Heart’s AccuCinch ventricular restoration system wins FDA breakthrough nod
Ancora Heart announced today that it received FDA breakthrough device designation for its AccuCinch ventricular restoration system. Santa Clara, California-based Ancora Heart designed its AccuCinch system to provide a minimally invasive treatment option for patients who have symptomatic heart failure (HF) with reduced ejection fraction (HFrEF). The company is currently evaluating the system in the […]
MedTech 100 roundup: Return to normal after last week’s spike
After rising more than 31 points to heights never before reached, the medtech industry returned to normal this past week. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 23) at 115.54 points, a total that, had it not been for the previous week, would […]
Ancora Heart raises $80M for ventricular restoration system
Ancora Heart announced today that it raised $80 million in equity financing for its AccuCinch ventricular restoration system. Santa Clara, Calif.–based Ancora Heart said in a news release that funds raised in the equity round are earmarked for the acceleration of the Corcinch-HF pivotal clinical study of the AccuCinch system for treating symptomatic heart failure […]
Ancora Heart says enrollment has started for AccuCinch pivotal trial
Ancora Heart this week said it has enrolled the first patient in its AccuCinch Ventricular Restoration System pivotal trial. AccuCinch is a flexible implant that is attached to the inner wall of the left ventricle and then cinched. It is designed to reduce the size of the left ventricle, reduce ventricular wall stress and support […]
Ancora Heart wins IDE for ventricular restoration system
Ancora Heart announced today that it received FDA investigational device exemption (IDE) for its AccuCinch ventricular restoration system. AccuCinch is designed to treat patients with heart failure and reduced ejection fraction (HFrEF) by directly reshaping the left ventricle of the heart to address the fundamental issue in the progression of systolic heart failure, according to […]
Ancora Heart launches AccuCinch study in Europe
Ancora Heart said today that the first patient was enrolled in a European multi-center clinical evaluation of its AccuCinch ventricular repair system intended for treating patients with reduced ejection fraction systolic heart failure. The first patient was enrolled at Homolka Hospital in Prague, Czech Republic, by Dr. Petr Neužil, head of the hospital’s cardiology department […]
Ancora Heart launches 2nd AccuCinch ventricular repair system feasibility study
Ancora Heart said yesterday that it launched a U.S.-based early feasibility study looking to evaluate its AccuCinch ventricular repair system intended for treating patients with reduce ejection fraction systolic heart failure. The first patient has already been enrolled in the study at UPMC Pinnacle Harrisburg by Dr. Hemal Gada and Dr. Mubashir Mumtaz, Santa Clara, […]
Ancora Heart raises $18m to support AccuCinch ventricular repair system
Heart-focused medtech developer Ancora Heart said today it raised $17.8 million in a new financing round to support its AccuCinch ventricular repair system designed for treating heart failure and functional mitral regurgitation. The funding round was led by Savitr Capital and other existing investors, the Santa Clara, Calif.-based company said. The company added that the […]
Integrated Endoscopy names Sharp as prez & CEO | Personnel Moves November 15, 2016
Integrated Endoscopy said today it tapped Brad Sharp as its new prez & CEO, as well as joining the company’s board. The company said it is making the move with Sharp in preparation of the launch of its Nevis single-use arthroscope, which is slated for early 2017. The company said it also named Rob Cripe […]
